Title:
グリコサミノグリカンを含む医薬組成物及び慢性潰瘍の処理へのその使用
Document Type and Number:
Japanese Patent JP2011526608
Kind Code:
A
Abstract:
The invention relates to a composition of glycosaminoglycans for the treatment of diabetic foot ulcer, it specifically relates to low molecular weight heparins (LMWHs) and very low molecular weight heparins (VLMWHs) in the treatment of chronic ulcers, particularly of diabetic foot ulcers, and more specifically in the manufacture of a medicinal product for the treatment of chronic ulcers, and particularly diabetic foot ulcers and pressure ulcers.
Inventors:
Lopez-Belmont Encina, Iban
Canales Majordo, Maria de los Angeles
Sebadera Miranda, Elena
Canales Majordo, Maria de los Angeles
Sebadera Miranda, Elena
Application Number:
JP2011515493A
Publication Date:
October 13, 2011
Filing Date:
June 30, 2009
Export Citation:
Assignee:
Laboratorios Pharmaceuticos Rovi, Sociedad Anonima
International Classes:
A61K31/737; A61K31/727; A61P17/02
Foreign References:
| US0006004A | 1849-01-09 |
Other References:
JPN6013061879; 戸田憲一ら: '新しいヘパリン修飾体の皮膚創傷治癒促進効果' 薬理と臨床 第１０巻，第５号, 2000, ｐ．３９９-４０４
JPN6013061882; 原武ら: 'ｔｏｐｉｃａｌ ｈａｅｍｏｔｈｅｒａｐｙが有効であった難治性糖尿病性足趾潰瘍' 皮膚病診療 Ｖｏｌ．３０，Ｎｏ．６, 2008, ｐ．６９５-６９８
JPN5011009797; ＫＡＬＡＮＩ Ｍ．: 'ＥＦＦＥＣＴ ＯＦ ＤＡＬＴＥＰＡＲＩＮ ＯＮ ＨＥＡＬＩＮＧ ＯＦ ＣＨＲＯＮＩＣ ＦＯＯＴ ＵＬＣＥＲＳ ＩＮ ＤＩＡＢＥＴＩＣ ＰＡＴＩＥＮＴＳ 以下備考' ＤＩＡＢＥＴＥＳ ＣＡＲＥ Ｖ２６ Ｎ９, 200309, Ｐ２５７５-２５８０
JPN5011009798; ＫＡＬＡＮＩ Ｍ．: 'ＢＥＮＥＦＩＣＩＡＬ ＥＦＦＥＣＴＳ ＯＦ ＤＡＬＴＥＰＡＲＩＮ ＯＮ ＨＡＥＭＯＳＴＡＴＩＣ ＦＵＮＣＴＩＯＮ ＡＮＤ ＬＯＣＡＬ ＴＩＳＳＵＥ ＯＸＹＧＥＮＡＴＩＯＮ 以下備考' ＴＨＲＯＭＢＯＳＩＳ ＲＥＳＥＡＲＣＨ Ｖ１２０, 2007, Ｐ６５３-６６１
JPN5011009799; ＪＩＶＥＧＡＲＤ Ｌ: 'ＥＦＦＥＣＴＳ ＯＦ ＴＨＲＥＥ ＭＯＮＴＨＳ ＯＦ ＬＯＷ ＭＯＬＥＣＵＬＡＲ ＷＥＩＧＨＴ ＨＥＰＡＲＩＮ （ＤＡＬＴＥＰＡＲＩＮ） ＴＲＥＡＴＭＥＮＴ 以下備考' ＥＵＲＯＰＥＡＮ ＪＯＵＲＮＡＬ ＯＦ ＶＡＳＣＵＬＡＲ ＡＮＤ ＥＮＤＯＶＡＳＣＵＬＡＲ ＳＵＲＧＥＲＹ Ｖ２９ Ｎ２, 20050201, Ｐ１９０-１９８, ＳＡＵＮＤＥＲＳ
JPN5011009800; ＲＯＺＩＮ Ａ． Ｐ．: 'ＲＥＣＡＬＣＩＴＲＡＮＴ ＬＥＧ ＵＬＣＥＲ ＤＵＥ ＴＯ ＭＩＸＥＤ ＣＯＮＮＥＣＴＩＶＥ ＴＩＳＳＵＥ ＤＩＳＥＡＳＥ' ＴＨＥ ＮＥＴＨＥＲＬＡＮＤＳ ＪＯＵＲＮＡＬ ＯＦ ＭＥＤＩＣＩＮＥ Ｖ６４ Ｎ３, 200603, Ｐ９１-９４
JPN5011009801; ＲＵＬＬＡＮ Ｍ．: 'ＥＮＳＡＹＯ ＣＬＩＮＩＣＯ， ＣＯＮＴＲＯＬＡＤＯ ＣＯＮ ＰＬＡＣＥＢＯ， ＴＲＩＰＬＥ ＣＩＥＧＯ， ＰＡＲＡ ＥＶＡＬＵＡＲ ＬＡ ＥＦＩＣＡＣＩＡ 以下備考' ＡＴＥＮ ＰＲＩＭＡＲＩＡ Ｖ３１ Ｎ８, 2003, Ｐ５３９-５４４
JPN6013061878; Ｌ．Ｔｏｒｋｖｉｓｔ ｅｔ．ａｌ．: 'Ｌｏｗ ｍｏｌｅｃｕｌａｒ ｗｅｉｇｈｔ ｈｅｐａｒｉｎ ａｓ ａｄｊｕｖａｎｔ ｔｈｅｒａｐｙ ｉｎ ａｃｔｉｖｅ ｕｌｃｅｒａｔｉｖｅ ｃｏｌｉｔｉｓ' Ａｌｉｍｅｎｔ Ｐｈａｒｍａｃｏｌ Ｔｈｅｒ Ｖｏｌ．１３，Ｎｏ．１０, 1999, ｐ．１３２３-１３２８
JPN6013061882; 原武ら: 'ｔｏｐｉｃａｌ ｈａｅｍｏｔｈｅｒａｐｙが有効であった難治性糖尿病性足趾潰瘍' 皮膚病診療 Ｖｏｌ．３０，Ｎｏ．６, 2008, ｐ．６９５-６９８
JPN5011009797; ＫＡＬＡＮＩ Ｍ．: 'ＥＦＦＥＣＴ ＯＦ ＤＡＬＴＥＰＡＲＩＮ ＯＮ ＨＥＡＬＩＮＧ ＯＦ ＣＨＲＯＮＩＣ ＦＯＯＴ ＵＬＣＥＲＳ ＩＮ ＤＩＡＢＥＴＩＣ ＰＡＴＩＥＮＴＳ 以下備考' ＤＩＡＢＥＴＥＳ ＣＡＲＥ Ｖ２６ Ｎ９, 200309, Ｐ２５７５-２５８０
JPN5011009798; ＫＡＬＡＮＩ Ｍ．: 'ＢＥＮＥＦＩＣＩＡＬ ＥＦＦＥＣＴＳ ＯＦ ＤＡＬＴＥＰＡＲＩＮ ＯＮ ＨＡＥＭＯＳＴＡＴＩＣ ＦＵＮＣＴＩＯＮ ＡＮＤ ＬＯＣＡＬ ＴＩＳＳＵＥ ＯＸＹＧＥＮＡＴＩＯＮ 以下備考' ＴＨＲＯＭＢＯＳＩＳ ＲＥＳＥＡＲＣＨ Ｖ１２０, 2007, Ｐ６５３-６６１
JPN5011009799; ＪＩＶＥＧＡＲＤ Ｌ: 'ＥＦＦＥＣＴＳ ＯＦ ＴＨＲＥＥ ＭＯＮＴＨＳ ＯＦ ＬＯＷ ＭＯＬＥＣＵＬＡＲ ＷＥＩＧＨＴ ＨＥＰＡＲＩＮ （ＤＡＬＴＥＰＡＲＩＮ） ＴＲＥＡＴＭＥＮＴ 以下備考' ＥＵＲＯＰＥＡＮ ＪＯＵＲＮＡＬ ＯＦ ＶＡＳＣＵＬＡＲ ＡＮＤ ＥＮＤＯＶＡＳＣＵＬＡＲ ＳＵＲＧＥＲＹ Ｖ２９ Ｎ２, 20050201, Ｐ１９０-１９８, ＳＡＵＮＤＥＲＳ
JPN5011009800; ＲＯＺＩＮ Ａ． Ｐ．: 'ＲＥＣＡＬＣＩＴＲＡＮＴ ＬＥＧ ＵＬＣＥＲ ＤＵＥ ＴＯ ＭＩＸＥＤ ＣＯＮＮＥＣＴＩＶＥ ＴＩＳＳＵＥ ＤＩＳＥＡＳＥ' ＴＨＥ ＮＥＴＨＥＲＬＡＮＤＳ ＪＯＵＲＮＡＬ ＯＦ ＭＥＤＩＣＩＮＥ Ｖ６４ Ｎ３, 200603, Ｐ９１-９４
JPN5011009801; ＲＵＬＬＡＮ Ｍ．: 'ＥＮＳＡＹＯ ＣＬＩＮＩＣＯ， ＣＯＮＴＲＯＬＡＤＯ ＣＯＮ ＰＬＡＣＥＢＯ， ＴＲＩＰＬＥ ＣＩＥＧＯ， ＰＡＲＡ ＥＶＡＬＵＡＲ ＬＡ ＥＦＩＣＡＣＩＡ 以下備考' ＡＴＥＮ ＰＲＩＭＡＲＩＡ Ｖ３１ Ｎ８, 2003, Ｐ５３９-５４４
JPN6013061878; Ｌ．Ｔｏｒｋｖｉｓｔ ｅｔ．ａｌ．: 'Ｌｏｗ ｍｏｌｅｃｕｌａｒ ｗｅｉｇｈｔ ｈｅｐａｒｉｎ ａｓ ａｄｊｕｖａｎｔ ｔｈｅｒａｐｙ ｉｎ ａｃｔｉｖｅ ｕｌｃｅｒａｔｉｖｅ ｃｏｌｉｔｉｓ' Ａｌｉｍｅｎｔ Ｐｈａｒｍａｃｏｌ Ｔｈｅｒ Ｖｏｌ．１３，Ｎｏ．１０, 1999, ｐ．１３２３-１３２８
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazuhiro Nakamura
Yoichi Watanabe
Masaru Nakajima
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazuhiro Nakamura
Yoichi Watanabe
Masaru Nakajima